Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1479-1494

  Lyon, Martha E ^a,b,c   DuBois, Jeffrey A ^d   Fick, Gordon H ^a   Lyon, Andrew W ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ascorbate; Bias; Glucose meters; Hematocrit; Imprecision; Interference; Maltose; Total error

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; MALTOSE;

ADULT; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; COMPARATIVE STUDY; EPIDEMIOLOGY; EQUIPMENT DESIGN; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HOSPITAL; HOSPITAL INFORMATION SYSTEM; HUMAN; INSTRUMENTATION; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; REFERENCE VALUE; REPRODUCIBILITY; STANDARD; STATISTICAL MODEL; TEST STRIP;

ADULT; ASCORBIC ACID; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; EQUIPMENT DESIGN; HEMATOCRIT; HOSPITALS; HUMANS; LINEAR MODELS; MALTOSE; MULTIVARIATE ANALYSIS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REAGENT STRIPS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 79952996013     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400624     Document Type: Article

References (24)

1. Mahoney J, Ellison J. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Clin Chem. 2007;53(6):1122-8.
2. Krouwer JS, Cembrowski GS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol. 2010;4(1):75-83.
3. Mahoney JJ, Ellison JM. Assessing glucose monitor performance - a standardized approach. Diabetes Technol Ther. 2007;9(6):545-52.
4. Lyon ME, Gray D, Baskin LB, Dubois JA, Lyon AW. A mathematical model to assess the influence of hematocrit on point of care glucose meter performance. Clin Biochem. 2010;43(10-11):905-9.
5. Klonoff DC. The Food and Drug Administration is now preparing to establish tighter performance requirements for blood glucose monitors. J Diabetes Sci Technol. 2010;4(3):499-504.
6. Westgard JO. Managing quality vs. measuring uncertainty in the medical laboratory. Clin Chem Lab Med. 2010;48(1):31-40.
7. Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline - third edition. POCT12-A3. CLSI (in preparation).
8. In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197: 2003.
9. Freckmann G, Baumstark A, Jendrike N, Zschornack E, Kocher S, Tshiananga J, Heister F, Haug C. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther. 2010;12(3):221-31.
10. Lyon ME, Baskin LB, Braakman S, Presti S, Dubois J, Shirey T. Interference studies with two hospital-grade and two home-grade glucose meters. Diabetes Technol Ther. 2009;11(10):641-7.
11. Fogh-Andersen N, Wimberley PD, Thode J, Siggaard-Andersen O. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. Clin Chim Acta 1990;189(1):33-8.
12. Kroll MH, Ruddel M, Blank DW, Elin RJ. A model for assessing interference. Clin Chem. 1987;33(7):1121-3.
13. Fogh-Andersen N, D'Orazio P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem. 1998;44(3):655-9.
14. Floré KM, Delanghe JR. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int. 2009;29(4):377-83.
15. Tsai CY, Lee SC, Hung CC, Lee JJ, Kuo MC, Hwang SJ, Chen HC. False elevation of blood glucose levels measured by GDH-PQQ-based glucometers occurs during all daily dwells in peritoneal dialysis patients using icodextrin. Perit Dial Int. 2010;30(3):329-35.
16. Cook A, Laughlin D, Moore M, North D, Wilkins K, Wong G, Wallace-Scroggs A, Halvorsen L. Differences in glucose values obtained from point-of-care glucose meters and laboratory analysis in critically ill patients. Am J Crit Care. 2009;18(1):65-71.
17. Karon BS, Griesmann L, Scott R, Bryant SC, Dubois JA, Shirey TL, Presti S, Santrach PJ. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther. 2008;10(2):111-20.
18. Baskin L, Gray D, Lyon ME. Pediatric hematocrit distribution in an acute-care hospital versus community setting. Clin Chem. 2008;54/6(Supplement): A195, E133.
19. Hassan GI, Gregory U, Maryam H. Serum ascorbic acid concentration in patients with acute Falciparum malaria infection: possible significance. Braz J Infect Dis. 2004;8(5):378-81.
20. Garba IH, Abraham IG, Shuaibu U. Serum L-ascorbic acid concentration and its potential for scavenging of reactive oxygen species in acute, uncomplicated, falciparum malaria infection. Internet J Infect Dis. 2006;5(2):[about 7 p.]. Available from: http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijid/ vol5n2/malaria.xml. Accessed June 1, 2010.
21. U.S. Food and Drug Administration. FDA public health notification: potentially fatal errors with GDH-PQQ glucose monitoring technology. [updated 2009 August 13]. Available from: http://www.fda.gov/medicaldevices/safety/ alertsandnotices/publichealthnotifications/ucm176992.htm.
22. U.S. Food and Drug Administration. Advice for patients: serious errors with certain blood glucose monitoring test strips. [updated 2009 August 18]. Available from: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PatientAlerts/ucm177189.htm.
23. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209-14.
24. Breton MD, Kovatchev BP. Impact of blood glucose self-monitoring error on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol. 2010;4(3):562-70.